Private Placement

Enveric Biosciences raises $1.5M to advance its novel psychiatric drugs. Is this small cash infusion enough to propel its promising pipeline forward?

Eliyan secures $50M from Meta, AMD, and Arm to scale its chiplet interconnects, a key technology for overcoming AI's data transfer limitations.

A landmark FDA decision allows Life Biosciences to test its epigenetic reprogramming therapy, ER-100, offering new hope for restoring sight in the blind.

With promising brain scan data, a deep therapeutic pipeline, and a cash runway into 2027, Radiopharm Theranostics is gaining significant momentum.

Nasdaq's new Monday & Wednesday options for tech giants are live. Discover how Futu's Moomoo is leading the charge and what this means for your strategy.

A landmark deal will see Hana Bank finance critical AI chip imports, aiming to reshape fintech and bolster South Korea's global technology standing.

AirDNA's 2026 report shatters investment norms, revealing the best short-term rental returns are in affordable cities driven by work, not vacations.

Eurodita launches a flexible private-label program for US & Canadian dealers, offering European glulam structures with no minimum orders.

Specialized firms are solving complex tax credit puzzles, enabling developers to bring affordable solar energy to more homes, including low-income areas.

Veteran leader Emma Rooth takes charge at PCCA UK, bringing a track record of transformation to the booming personalized medicine market.

Top-tier credit ratings and a strategic partnership with global giant MUFG are set to reshape Shriram Finance's future and the Indian NBFC landscape.

Nuvve's new partnership with Capture Energy for modular battery systems aims to accelerate its V2G and grid services expansion across the Nordics.

With gold prices soaring past $5,000, one junior miner is betting on a vertically integrated model to turn record highs into major profits.

Baird Medical partners with Stonewood Key Capital, using China's Hainan Free Trade Port to accelerate its global push for minimally invasive therapies.

A major shift in defense contracting, fueled by a $1.5T private capital wave, demands field-ready tech. Companies that can deliver are poised to win.

Onity Group is raising $150 million via high-yield notes, a strategic but risky move to refinance debt and fund growth amid a complex financial backdrop.

A first-in-class oral therapy targeting cellular metabolism has entered patient trials, offering new hope for a disease-modifying treatment for eczema.

As labor shortages persist, new data shows autonomous mowers are no longer a novelty but a proven tool boosting productivity for landscape leaders.

With major government backing, Canada Nickel's massive Crawford project accelerates, promising to be a key supplier for the EV market and a nation-building force.

A new partnership between Mair Therapeutics and Radboud University aims to fix the cell's waste disposal system, a novel approach for Parkinson's disease.